ArticleJCEM case reports2025

Extending the Graves' Triad: Thyroid Eye Disease, Dermopathy, and Acropachy: A Clinical Response to Teprotumumab.

Javier Lira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.